Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹1,021.75
Day range
₹1,003.35 - ₹1,034.60
Year range
₹620.85 - ₹1,072.45
Market cap
53.79B INR
Avg Volume
5.65K
P/E ratio
59.19
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.87B | 21.34% |
Operating expense | 602.90M | 61.94% |
Net income | 217.00M | 22.05% |
Net profit margin | 11.59 | 0.52% |
Earnings per share | 4.16 | 17.51% |
EBITDA | 577.45M | 82.58% |
Effective tax rate | 54.29% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92B | 31.30% |
Total assets | 6.93B | 7.59% |
Total liabilities | 1.46B | 25.33% |
Total equity | 5.47B | — |
Shares outstanding | 52.04M | — |
Price to book | 9.72 | — |
Return on assets | — | — |
Return on capital | 20.36% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 217.00M | 22.05% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,693
